Literature DB >> 31541199

Combining immunotherapy and radiotherapy for the STAR treatment.

Jordan A Torok1,2, Joseph K Salama3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31541199     DOI： 10.1038/s41571-019-0277-2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

Review 1.  State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis.

Authors:  Masoumeh Najafi; Amin Jahanbakhshi; Marzieh Gomar; Cinzia Iotti; Lucia Giaccherini; Omid Rezaie; Francesco Cavallieri; Letizia Deantonio; Lilia Bardoscia; Andrea Botti; Angela Sardaro; Salvatore Cozzi; Patrizia Ciammella
Journal:  Curr Oncol       Date:  2022-04-22       Impact factor: 3.109

2.  CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab.

Authors:  Lei Kang; Cuicui Li; Zachary T Rosenkrans; Nan Huo; Zhao Chen; Emily B Ehlerding; Yan Huo; Carolina A Ferreira; Todd E Barnhart; Jonathan W Engle; Rongfu Wang; Dawei Jiang; Xiaojie Xu; Weibo Cai
Journal:  Adv Sci (Weinh)       Date:  2021-03-15       Impact factor: 16.806

3.  Adhesion and Migration Response to Radiation Therapy of Mammary Epithelial and Adenocarcinoma Cells Interacting with Different Stiffness Substrates.

Authors:  Valeria Panzetta; Giuseppe La Verde; Mariagabriella Pugliese; Valeria Artiola; Cecilia Arrichiello; Paolo Muto; Marco La Commara; Paolo A Netti; Sabato Fusco
Journal:  Cancers (Basel)       Date:  2020-05-06       Impact factor: 6.639

4.  Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report.

Authors:  Agostino Cristaudo; Antonio Malorgio; Serena Medoro; Antonio Stefanelli
Journal:  Radiat Oncol J       Date:  2021-03-03

Review 5.  Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review.

Authors:  Vincent Bourbonne; Margaux Geier; Ulrike Schick; François Lucia
Journal:  Biomedicines       Date:  2022-05-26

6.  Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.

Authors:  F Vilotte; D Pasquier; P Blanchard; S Supiot; J Khalifa; U Schick; T Lacornerie; L Vieillevigne; D Marre; O Chapet; I Latorzeff; N Magne; E Meyer; K Cao; Y Belkacemi; J E Bibault; M Berge-Lefranc; J C Faivre; K Gnep; V Guimas; A Hasbini; J Langrand-Escure; C Hennequin; P Graff
Journal:  Clin Transl Radiat Oncol       Date:  2022-08-08

Review 7.  Role of modern radiotherapy in managing patients with hepatocellular carcinoma.

Authors:  Liang-Cheng Chen; Hon-Yi Lin; Shih-Kai Hung; Wen-Yen Chiou; Moon-Sing Lee
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

8.  Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Chi-Leung Chiang; Keith Wan-Hang Chiu; Francis Ann-Shing Lee; Feng-Ming Spring Kong; Albert Chi-Yan Chan
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.